Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZTherapies Doses First Patient in ALZT-OP1a Study for ALS

americanpharmaceuticalreviewSeptember 16, 2020

Tag: AZTherapies , ALZT-OP1a , ALS

PharmaSources Customer Service